{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T11:20:47Z","timestamp":1768389647466,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24ES030894"],"award-info":[{"award-number":["R24ES030894"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD096032"],"award-info":[{"award-number":["R01HD096032"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Compare cardiometabolic trajectories of 557 parous women with diagnosed, probable, and no polycystic ovary syndrome (PCOS) throughout 15-year follow-up (2002-2021). We defined PCOS status as: (1) clinically diagnosed; (2) probable: without diagnosis but \u22652 of the following: cycle length\u00a0&amp;lt;21 or\u00a0\u226535\u00a0days, free testosterone &amp;gt;75th percentile, or anti-M\u00fcllerian hormone &amp;gt;75th percentile; (3) no PCOS. Outcomes included longitudinal adiposity, blood pressure, lipids, glycemia, and adipokines. We used mixed-effects models to examine associations of PCOS status with the outcomes, adjusting for covariates. Women were 37\u00a0\u00b1\u00a05 years at baseline; 9.7% had diagnosed and 9.2% probable PCOS. Throughout follow-up, women with diagnosed versus no PCOS had higher adiposity, systolic blood pressure, triglycerides, hemoglobin A1c, fasting glucose, insulin, and leptin; and lower high-density lipoprotein and adiponectin. However, the diagnosed and probable PCOS groups had similar hemoglobin A1c (0.16 [95% CI, -0.20 to 0.52]), leptin (-4.20 [95% CI, -16.61 to 8.22] ng\/mL), and adiponectin (0.99 [95% CI, -2.15 to 4.13] \u03bcg\/mL). Both groups had less favorable profiles than women without PCOS, even after body mass index adjustment. Although women with diagnosed PCOS have the least favorable cardiometabolic profile throughout midlife, those with probable PCOS exhibited comparable glycemia and an altered adipokine pattern suggestive of adipocyte dysfunction independent of adiposity.<\/jats:p>","DOI":"10.1093\/aje\/kwaf078","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T10:50:17Z","timestamp":1745405417000},"page":"2447-2456","source":"Crossref","is-referenced-by-count":1,"title":["Cardiometabolic trajectories across midlife in parous women with polycystic ovary syndrome"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-8707","authenticated-orcid":false,"given":"Yingan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado, Anschutz Medical Campus , Aurora, CO ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Salmon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado, Anschutz Medical Campus , Aurora, CO ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheryl L","family":"Rifas-Shiman","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research across the Lifecourse (CORaL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria W","family":"Fitz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Massachusetts General Hospital , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Kazemi","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Harvard T. H. Chan School of Public Health , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Shifren","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Massachusetts General Hospital , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Hivert","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research across the Lifecourse (CORaL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston, MA ,","place":["United States"]},{"name":"Diabetes Unit, Massachusetts General Hospital , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Oken","sequence":"additional","affiliation":[{"name":"Division of Chronic Disease Research across the Lifecourse (CORaL), Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute , Boston, MA ,","place":["United States"]},{"name":"Department of Nutrition, Harvard T. H. Chan School of Public Health , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Chavarro","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Harvard T. H. Chan School of Public Health , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8552-6850","authenticated-orcid":false,"given":"Wei","family":"Perng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado, Anschutz Medical Campus , Aurora, CO ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2026011400530089100_ref1","author":"Center for Disease Control and Prevention","year":"30, 2022"},{"issue":"6","key":"2026011400530089100_ref2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod"},{"issue":"1","key":"2026011400530089100_ref3","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487","article-title":"Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research","volume":"21","author":"Harada","year":"2022","journal-title":"Reprod Med Biol."},{"issue":"2","key":"2026011400530089100_ref4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1530\/ec-19-0496","article-title":"Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age","volume":"9","author":"Medeiros","year":"2020","journal-title":"Endocr Connect."},{"issue":"12","key":"2026011400530089100_ref5","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s40618-021-01594-5","article-title":"Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome","volume":"44","author":"Falcetta","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"2026011400530089100_ref6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020\u2021","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod."},{"issue":"1","key":"2026011400530089100_ref7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"5","key":"2026011400530089100_ref8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026011400530089100_ref9","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026011400530089100_ref10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril."},{"issue":"7","key":"2026011400530089100_ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012461","article-title":"Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study","volume":"6","author":"Ding","year":"2016","journal-title":"BMJ Open."},{"key":"2026011400530089100_ref12","author":"World Health Organization"},{"issue":"1","key":"2026011400530089100_ref13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/aje\/kwae179","article-title":"Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women","volume":"194","author":"Perng","year":"2024","journal-title":"Am J Epidemiol."},{"issue":"6","key":"2026011400530089100_ref14","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1093\/ije\/dyad137","article-title":"Cohort profile update: Project Viva mothers","volume":"52","author":"Rifas-Shiman","year":"2023","journal-title":"Int J Epidemiol."},{"issue":"6","key":"2026011400530089100_ref15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/s2213-8587(22)00076-6","article-title":"Menopause: a cardiometabolic transition","volume":"10","author":"Nappi","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2026011400530089100_ref16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3390\/diagnostics13050929","article-title":"The triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease","volume":"13","author":"Kosmas","year":"2023","journal-title":"Diagnostics (Basel)."},{"issue":"5","key":"2026011400530089100_ref17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/01.mco.0000171130.23441.59","article-title":"Assessment of insulin secretion in relation to insulin resistance","volume":"8","author":"Mari","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"2026011400530089100_ref18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1186\/s12884-022-04885-8","article-title":"History of infertility and pregnancy outcomes in Project Viva: a prospective study","volume":"22","author":"Soria-Contreras","year":"2022","journal-title":"BMC Pregnancy Childbirth."},{"issue":"5","key":"2026011400530089100_ref19","doi-asserted-by":"publisher","first-page":"E841","DOI":"10.1210\/jc.2013-3918","article-title":"Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS","volume":"99","author":"Roe","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2026011400530089100_ref20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/jc.2018-00570","article-title":"Self-reported polycystic ovary syndrome is associated with hypertension: A northern Finland birth cohort 1966 study","volume":"104","author":"Ollila","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2026011400530089100_ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002953","article-title":"Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: a case-control study","volume":"16","author":"Ng","year":"2019","journal-title":"PLoS Med"},{"issue":"12","key":"2026011400530089100_ref22","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.2337\/dc21-0437","article-title":"Polycystic ovary syndrome, combined oral contraceptives, and the risk of dysglycemia: a population-based cohort study with a nested pharmacoepidemiological case-control study","volume":"44","author":"Kumarendran","year":"2021","journal-title":"Diabetes Care"},{"key":"2026011400530089100_ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.574651","article-title":"Hypertension risk in young women with polycystic ovary syndrome: a nationwide population-based cohort study","volume":"7","author":"Wu","year":"2020","journal-title":"Front Med (Lausanne)."},{"issue":"5","key":"2026011400530089100_ref24","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2026011400530089100_ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.552421","article-title":"Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Cardiovasc Med."},{"issue":"16","key":"2026011400530089100_ref26","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.123.033572","article-title":"2023 international evidence-based polycystic ovary syndrome guideline update: insights from a systematic review and meta-analysis on elevated clinical cardiovascular disease in polycystic ovary syndrome","volume":"13","author":"Tay","year":"2024","journal-title":"J Am Heart Assoc."},{"issue":"1","key":"2026011400530089100_ref27","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1038\/s41598-017-04162-1","article-title":"Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target","volume":"7","author":"Marangoni","year":"2017","journal-title":"Sci Rep."},{"issue":"3","key":"2026011400530089100_ref28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s42255-019-0041-z","article-title":"Metabolic messengers: adiponectin","volume":"1","author":"Straub","year":"2019","journal-title":"Nat Metab."},{"issue":"1","key":"2026011400530089100_ref29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5507\/bp.2017.002","article-title":"Adipokines and cardiovascular disease: a comprehensive review","volume":"161","author":"Smekal","year":"2017","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"2026011400530089100_ref30","doi-asserted-by":"publisher","first-page":"1260623","DOI":"10.3389\/fendo.2023.1260623","article-title":"Early detection of type 2 diabetes risk: limitations of current diagnostic criteria","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10448","key":"2026011400530089100_ref31","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/s0140-6736(24)00827-4","article-title":"Pathophysiology from preconception, during pregnancy, and beyond","volume":"404","author":"Hivert","year":"2024","journal-title":"Lancet."},{"issue":"2","key":"2026011400530089100_ref32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/jhrs.JHRS_2_19","article-title":"Body composition, metabolic characteristics, and insulin resistance in obese and nonobese women with polycystic ovary syndrome","volume":"12","author":"Satyaraddi","year":"2019","journal-title":"J Hum Reprod Sci"},{"issue":"6","key":"2026011400530089100_ref33","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1210\/clinem\/dgab134","article-title":"Incidence and predictors of hypertension in a cohort of Australian women with and without polycystic ovary syndrome","volume":"106","author":"Joham","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2026011400530089100_ref34","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \"risk-enhancing\" factor for cardiovascular disease","volume":"117","author":"Guan","year":"2022","journal-title":"Fertil Steril."},{"key":"2026011400530089100_ref35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/ijwh.S11304","article-title":"Treatment options for polycystic ovary syndrome","volume":"3","author":"Badawy","year":"2011","journal-title":"Int J Womens Health."},{"issue":"1","key":"2026011400530089100_ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191327","article-title":"Bias due to differential participation in case-control studies and review of available approaches for adjustment","volume":"13","author":"Aigner","year":"2018","journal-title":"PloS One."},{"key":"2026011400530089100_ref37","volume-title":"Congenital Adrenal Hyperplasia","author":"Sharma","year":"2025"},{"issue":"1","key":"2026011400530089100_ref38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12905-022-01782-2","article-title":"Serum anti-M\u00fcllerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age","volume":"22","author":"Butt","year":"2022","journal-title":"BMC Womens Health."},{"issue":"4","key":"2026011400530089100_ref39","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal","year":"2020","journal-title":"J Hum Reprod Sci."},{"key":"2026011400530089100_ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.985588","article-title":"Assessment of prevalence, knowledge of polycystic ovary syndrome and health-related practices among women in klang valley: a cross-sectional survey","volume":"13","author":"Goh","year":"2022","journal-title":"Front Endocrinol (Lausanne)."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwaf078\/62993471\/kwaf078.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/194\/9\/2447\/62993471\/kwaf078.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/194\/9\/2447\/62993471\/kwaf078.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:53:09Z","timestamp":1768369989000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/194\/9\/2447\/8118583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,9,3]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwaf078","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,4,22]]}}}